Liminatus Pharma, Inc. Warrants (LIMNW) Stock Ticker
$0.0437+0.00%
USD · as of 2026-09-29 · market cap $1.2M
Market factors today
Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD
Unlock the full LIMNW picture
🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on LIMNW
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
About Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.
LIMNW stock facts
| Ticker symbol | LIMNW |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.2M |
| CEO | Chris Kim |
| Employees | 1 |
| Headquarters | Cerritos, CA, US |
| IPO date | 2025-04-30 |
| Website | liminatuspharma.com |
What you can see for LIMNW on Tickr
Live LIMNW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LIMNW report.
Rankings
FAQ
What is the ticker symbol for Liminatus Pharma, Inc. Warrants?
The ticker symbol for Liminatus Pharma, Inc. Warrants is LIMNW, listed on the NASDAQ Global Select.
What is LIMNW?
Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.